BioHarvest Sciences Inc. (CNVCF) Comparison with companies in other sectors?

BioHarvest Sciences Inc. has a share price of 17.33M. You can analyze BioHarvest Sciences Inc. (CNVCF) competitors across different market sectors through stock heatmaps.

What are CNVCF's NET and operating margins?

BioHarvest Sciences Inc. (CNVCF) operating margin is around -0.35, and net profit margin is approximately -0.77 as of the latest reports.

In what way does CNVCF's earnings per share (EPS) trend reflect its financial momentum?

BioHarvest Sciences Inc. (CNVCF) EPS is -1.26 (If EPS value is positive, then “signals consistent profit growth” if Negative then “signals consistent loss”). This metric is also critical in assessing valuation metrics like the P/E ratio for BioHarvest Sciences Inc. is -5.00, and the company’s ability to reinvest or distribute profits.

What does a high ROE mean for BioHarvest Sciences Inc.?

A high ROE suggests efficient use of shareholder equity to generate profit. It often signals strong management and profitability.

How do I know if AAPL is overvalued or undervalued?

Check valuation ratios for BioHarvest Sciences Inc. like P/E which is -5.39, P/B which is 22.39, and PEG which is -0.49. Compare them with sector averages to evaluate if the stock is priced fairly.

BioHarvest Sciences Inc.

CNVCF•PNK

Healthcare

Drug Manufacturers - Specialty & Generic

$6.30

$0.00(0.00%)

Fundamental Analysis of BioHarvest Sciences Inc. (CNVCF)

Comprehensive financial metrics and ratios analysis

EPS (TTM)

$-1.26

P/E Ratio

-5.00

ROE

9.56%

Net Margin

-0.77%

Key Financial Metrices

Valuation Metrics

4 metrics

Market CapTotal market value of outstanding shares

$109.16M

Shares OutstandingTotal number of shares issued

$17.33M

Book Value/ShareNet worth per share

$0.28

Revenue/ShareAnnual revenue per share

$1.52

Profitability Metrics

6 metrics

EPS (TTM)Earnings per share trailing twelve months

$-1.26

Net MarginNet income as percentage of revenue

-76.65%

Operating MarginOperating income as percentage of revenue

-35.00%

ROEReturn on shareholders' equity

955.64%

ROAReturn on total assets

-66.58%

ROCEReturn on capital employed

-49.40%

Cash Flow Metrics

3 metrics

Free Cash Flow/ShareCash generated per share after capex

$-0.68

Cash/ShareCash and equivalents per share

$0.19

FCF YieldFree cash flow as percentage of market cap

-9.18%

Dividend Metrics

2 metrics

Dividend/ShareAnnual dividend payment per share

Dividend YieldAnnual dividend as percentage of stock price

Financial Ratios Analysis data is not available for CNVCFFinancial Ratios Analysis details for CNVCF are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Sector Benchmarking data is not available for CNVCFSector Benchmarking details for CNVCF are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Understanding Fundamental Analysis for BioHarvest Sciences Inc. Investment Decisions

What is Fundamental Analysis?

Fundamental analysis is a method used to assess the intrinsic value of BioHarvest Sciences Inc.. Using financial reports, management structure, competitive position, and market environment, investors can determine whether the stock is undervalued or overvalued. This analysis helps investors like you make more informed investment decisions, taking into account BioHarvest Sciences Inc.'s unique business strengths and challenges.

Key Financial Metrics for BioHarvest Sciences Inc.

For BioHarvest Sciences Inc., essential financial indicators include EPS -1.26, PE -5.00, and ROE 9.56. These key ratios reveal insights into BioHarvest Sciences Inc.'s profitability, valuation, and operational health. Understanding these metrics enables you to compare BioHarvest Sciences Inc. with its industry peers and decide whether it presents a viable investment opportunity.

Profitability and Operational Efficiency of BioHarvest Sciences Inc.

Metrics like Net Margin -76.65% and ROA -66.58% shed light on how well BioHarvest Sciences Inc. is generating profits. A high profitability ratio often indicates strong management and a solid business model, which are essential for long-term growth. These metrics are crucial in assessing whether BioHarvest Sciences Inc. can sustain its operations and continue growing in the future.

Valuation and Market Position of BioHarvest Sciences Inc.

Using ratios such as P/B Ratio 22.39 and PEG Ratio -0.49, investors can assess whether BioHarvest Sciences Inc. is appropriately valued based on its financials and growth potential. These figures, combined with BioHarvest Sciences Inc.'s market capitalization, give insight into its competitive positioning and investor expectations, helping you make informed decisions on pricing and value.

Financial Health and Risk Assessment for BioHarvest Sciences Inc.

Financial health indicators, such as Debt/Equity Ratio 2.58 and Cash Flow $-0.68, provide a snapshot of BioHarvest Sciences Inc.'s ability to meet financial obligations and handle economic setbacks. A company with a strong balance sheet and solid cash flow, like BioHarvest Sciences Inc., is more likely to weather financial storms, making it a safer investment.

Long-Term Investment Strategy for BioHarvest Sciences Inc.

Investing in BioHarvest Sciences Inc. based on fundamental analysis emphasizes long-term business growth rather than short-term market trends. Investors looking at BioHarvest Sciences Inc. focus on its solid financial performance, industry standing, and competitive advantages, all of which suggest sustainable growth and the potential for steady returns over time.

Fundamental Analysis FAQ

;